Skip to main content

Table 2 Overview of immune system (OVIS)

From: Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α

Cell populations

Controls (n = 20)

CML patients

p value#

Mean

95% CI

TKIs (n = 33)

TKIs plus IFN-α (n = 8)

Mean

95% CI

p value

Mean

95% CI

p value

Granulocytes

3971.9

(3195.1–4937.6)

3752.5

(3167.6–4445.3)

1.000

4051.7

(2872.1–5715.9)

1.000

1.000

Monocytes

328.7

(261.2–413.6)

381.5

(319.0–456.2)

0.930

466.4

(324.4–670.7)

0.326

0.973

CD45low

140.9

(104.5–189.9)

64.8

(51.4–81.8)

0.001

56.1

(35.0–90.0)

0.005

1.000

Lymphocytes

2059.4

(1660.5–2554.1)

1852.7

(1566.9–2190.8)

1.000

1140.3

(811.3–1602.6)

0.014

0.039

 B cells

241.9

(176.2–332.1)

147.9

(115.6–189.3)

0.052

171.6

(104.0–283.1)

0.751

1.000

 T cells

1500.3

(1207.0–1864.9)

1324.3

(1118.0–1568.7)

1.000

837.9

(594.1–1181.9)

0.017

0.060

  CD4+

1016.4

(813.2–1270.4)

758.0

(637.1–901.7)

0.104

504.7

(354.7–718.1)

0.004

0.105

    Naive

358.5

(264.0–486.9)

230.7

(181.8–292.7)

0.067

173.1

(103.2–290.3)

0.048

0.573

    Central memory (CM)

344.3

(271.2–437.1)

238.3

(197.9–286.9)

0.047

183.8

(122.8–275.1)

0.026

0.475

    Effector memory (EM)

13.7

(6.9–27.1)

18.2

(10.7–31.0)

0.791

7.1

(2.2–22.6)

0.596

0.311

    EM CD45 RA+ (EMRA)

4.2

(2.1–8.1)

11.9

(7.0–20.1)

0.044

4.6

(1.5–14.3)

0.988

0.289

  CD8+

207.1

(152.5–281.4)

327.7

(258.2–416.0)

0.055

193.2

(119.0–313.7)

0.968

0.132

    Naive

42.9

(29.1–63.2)

51.7

(38.2–69.8)

0.730

57.2

(31.0–105.5)

0.708

0.952

    Central memory (CM)

39.5

(28.7–54.3)

48.1

(37.5–61.6)

0.595

35.6

(21.5–58.9)

0.936

0.536

    Effector memory (EM)

5.2

(2.9–9.4)

19.7

(12.4–31.2)

0.002

10.5

(4.1–26.8)

0.411

0.454

    EM CD45 RA+ (EMRA)

13.3

(7.5–23.6)

74.7

(47.7–117.0)

0.001

23.0

(9.3–57.2)

0.566

0.060

  CD4+/CD8+

228.3

(168.0–310.2)

126.3

(99.5–160.3)

0.009

82.0

(50.5–133.1)

0.002

0.253

 NK cells

243.4

(175.1–338.3)

233.4

(180.7–301.6)

1.000

159.1

(94.6–267.7)

0.517

0.573

  CD56Dim

243.3

(174.0–340.2)

266.2

(205.1–345.6)

0.906

135.8

(80.0–230.7)

0.159

0.067

  CD56Bright

11.2

(7.3–17.3)

6.3

(4.5–8.8)

0.092

28.6

(14.5 - 56.5)

0.060

0.001

 CD56+ T cells

60.6

(36.9–99.6)

41.4

(28.1–61.0)

0.697

8.8

(4.019.4)

0.001

0.002

  CD4+

14.0

(8.7–22.5)

7.9

(5.4–11.5)

0.154

2.4

(1.05.7)

0.002

0.039

  CD8+

15.8

(9.3–26.8)

19.0

(12.4–29.1)

0.848

6.6

(2.5–17.3)

0.259

0.119

  CD4+/CD8+

22.0

(13.4–36.3)

9.8

(6.614.7)

0.038

3.6

(1.48.9)

0.003

0.111

  1. p value: statistical comparison vs control. p value # statistical comparison between TKIs and TKIs plus IFN-α. Cell populations with p < 0.050 are highlighted in italic